Wolfgang Albrecht
Chief Executive Officer at HepaRegeniX GmbH
Wolfgang Albrecht active positions
| Companies | Position | Start | End |
|---|---|---|---|
Landesbank Baden-Württemberg (Broker)
 Landesbank Baden-Württemberg (Broker) Investment Banks/BrokersFinance Landesbank Baden-Württemberg (Broker) (LBBW-Broker) is the brokerage division of Landesbank Baden-Württemberg in Germany. Headquartered in Stuttgart, the firm was founded in 1999 and provides capital market services to medium-sized companies, listed groups, institutional customers, savings banks and retail customers. | Analyst-Equity | - | - |
| Market Strategist | 1984-12-31 | - | |
HepaRegeniX GmbH
 HepaRegeniX GmbH Miscellaneous Commercial ServicesCommercial Services HepaRegeniX GmbH engages in the development of treatment for acute and chronic liver diseases. It focuses on Mitogen-Activated Protein Kinase 4, which unlocks the regenerative capacity of hepatocytes even in severely diseased livers. The company was founded in by Wolfgang Albrecht in 2017 and is headquartered in Tuebingen, Germany. | Chief Executive Officer | 2016-12-31 | - |
| Chief Operating Officer | 2019-09-30 | - | |
| Founder | 2016-12-31 | - |
Career history of Wolfgang Albrecht
Former positions of Wolfgang Albrecht
| Companies | Position | Start | End |
|---|---|---|---|
| Bankgesellschaft Berlin AG (Berlin Branch) | Analyst-Equity | - | - |
Statistics
International
| Germany | 4 |
Operational
| Analyst-Equity | 2 |
| Market Strategist | 1 |
| Chief Executive Officer | 1 |
Sectoral
| Finance | 3 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 3 |
|---|---|
Landesbank Baden-Württemberg (Broker)
Landesbank Baden-Württemberg (Broker) Investment Banks/BrokersFinance Landesbank Baden-Württemberg (Broker) (LBBW-Broker) is the brokerage division of Landesbank Baden-Württemberg in Germany. Headquartered in Stuttgart, the firm was founded in 1999 and provides capital market services to medium-sized companies, listed groups, institutional customers, savings banks and retail customers. | Finance |
HepaRegeniX GmbH
HepaRegeniX GmbH Miscellaneous Commercial ServicesCommercial Services HepaRegeniX GmbH engages in the development of treatment for acute and chronic liver diseases. It focuses on Mitogen-Activated Protein Kinase 4, which unlocks the regenerative capacity of hepatocytes even in severely diseased livers. The company was founded in by Wolfgang Albrecht in 2017 and is headquartered in Tuebingen, Germany. | Commercial Services |
| Bankgesellschaft Berlin AG (Berlin Branch) | Finance |
- Stock Market
- Insiders
- Wolfgang Albrecht
- Experience
